omeprazole has been researched along with Cholestasis in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Cholestasis: Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
Excerpt | Relevance | Reference |
---|---|---|
"Patients treated for cholestasis or liver diseases were removed." | 5.51 | Population Scale Retrospective Analysis Reveals Potential Risk of Cholestasis in Pregnant Women Taking Omeprazole, Lansoprazole, and Amoxicillin. ( Abagyan, R; Dai, W; Dong, M; Shi, D; Zhang, Y, 2019) |
" This study aimed to develop an animal model to examine the effects of long-term use of PPI in vivo." | 1.56 | Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats. ( Chang, HW; Chang, VHS; Chien, LN; Chu, PG; Dong, F; Jia, W; Lin, IH; Liu, YR; Wu, MJ; Xie, G; Yang, YSH; Yen, Y, 2020) |
"Patients treated for cholestasis or liver diseases were removed." | 1.51 | Population Scale Retrospective Analysis Reveals Potential Risk of Cholestasis in Pregnant Women Taking Omeprazole, Lansoprazole, and Amoxicillin. ( Abagyan, R; Dai, W; Dong, M; Shi, D; Zhang, Y, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Yang, YSH | 1 |
Chang, HW | 1 |
Lin, IH | 1 |
Chien, LN | 1 |
Wu, MJ | 1 |
Liu, YR | 1 |
Chu, PG | 1 |
Xie, G | 1 |
Dong, F | 1 |
Jia, W | 1 |
Chang, VHS | 1 |
Yen, Y | 1 |
Zhang, Y | 1 |
Shi, D | 1 |
Abagyan, R | 1 |
Dai, W | 1 |
Dong, M | 1 |
Dahlke, MH | 1 |
Aselmann, H | 1 |
Ceylan, D | 1 |
Bellin, T | 1 |
Flemming, P | 1 |
Meier, PN | 1 |
Oldhafer, K | 1 |
Klempnauer, J | 1 |
Schlitt, HJ | 1 |
Piso, P | 1 |
Mertens, PR | 1 |
Schönfelder, T | 1 |
Handt, S | 1 |
Kierdorf, H | 1 |
Marschall, H | 1 |
Busch, N | 1 |
Heintz, B | 1 |
Sieberth, H | 1 |
Namba, S | 1 |
5 other studies available for omeprazole and Cholestasis
Article | Year |
---|---|
Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Bile Duct Neoplasms; Bile Ducts; Cell Transformatio | 2020 |
Population Scale Retrospective Analysis Reveals Potential Risk of Cholestasis in Pregnant Women Taking Omeprazole, Lansoprazole, and Amoxicillin.
Topics: Adolescent; Adult; Amoxicillin; Child; Cholestasis; Drug Therapy, Combination; Female; Humans; Lanso | 2019 |
Effectiveness of peripheral hepatogastrostomy versus hepatojejunostomy in the treatment of obstructive cholestasis: results of an experimental model.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cholestasis; Common Bile Duct; Fea | 2004 |
Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion.
Topics: Acute Kidney Injury; Bile Acids and Salts; Charcoal; Chemical and Drug Induced Liver Injury; Cholest | 1998 |
[Inhibitory effects of omeprazole and cimetidine on the formation of gastric ulcer in rats with obstructive jaundice and acute renal failure].
Topics: Acute Kidney Injury; Animals; Cholestasis; Cimetidine; Gastric Mucosa; Male; Omeprazole; Rats; Rats, | 1988 |